| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |